SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-025525
Filing Date
2020-05-14
Accepted
2020-05-14 17:27:45
Documents
71
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bioc-10q_20200331.htm 10-Q 1845609
2 EX-31.1 bioc-ex311_6.htm EX-31.1 15384
3 EX-31.2 bioc-ex312_7.htm EX-31.2 15440
4 EX-32.1 bioc-ex321_8.htm EX-32.1 5267
5 EX-32.2 bioc-ex322_9.htm EX-32.2 5900
  Complete submission text file 0001564590-20-025525.txt   7183090

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bioc-20200331.xml EX-101.INS 1477309
7 XBRL TAXONOMY EXTENSION SCHEMA bioc-20200331.xsd EX-101.SCH 71394
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bioc-20200331_cal.xml EX-101.CAL 55580
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bioc-20200331_def.xml EX-101.DEF 208860
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bioc-20200331_lab.xml EX-101.LAB 483608
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bioc-20200331_pre.xml EX-101.PRE 379806
Mailing Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121 858-320-8200
BIOCEPT INC (Filer) CIK: 0001044378 (see all company filings)

IRS No.: 800943522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36284 | Film No.: 20879176
SIC: 8071 Services-Medical Laboratories